NS Partners’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $38.5M | Sell |
358,651
-9,538
| -3% | -$1.02M | 1.57% | 18 |
|
|
2025
Q1 | $37.1M | Buy |
368,189
+5,704
| +2% | +$575K | 1.63% | 19 |
|
|
2024
Q4 | $32.4M | Sell |
362,485
-6,046
| -2% | -$540K | 1.34% | 24 |
|
|
2024
Q3 | $30.9M | Buy |
368,531
+8,980
| +2% | +$753K | 1.3% | 26 |
|
|
2024
Q2 | $27.7M | Buy |
359,551
+1,669
| +0.5% | +$129K | 1.26% | 27 |
|
|
2024
Q1 | $24.5M | Buy |
357,882
+2,005
| +0.6% | +$137K | 1.13% | 32 |
|
|
2023
Q4 | $20.6M | Buy |
355,877
+1,699
| +0.5% | +$98.2K | 1% | 40 |
|
|
2023
Q3 | $18.7M | Sell |
354,178
-3,804
| -1% | -$201K | 1.01% | 40 |
|
|
2023
Q2 | $19.4M | Sell |
357,982
-2,644
| -0.7% | -$143K | 1.02% | 43 |
|
|
2023
Q1 | $18M | Buy |
360,626
+266
| +0.1% | +$13.3K | 1.01% | 47 |
|
|
2022
Q4 | $16.7M | Buy |
360,360
+1,489
| +0.4% | +$68.9K | 1.01% | 48 |
|
|
2022
Q3 | $13.9M | Buy |
358,871
+14,161
| +4% | +$548K | 0.9% | 49 |
|
|
2022
Q2 | $12.8M | Buy |
344,710
+3,483
| +1% | +$130K | 0.78% | 51 |
|
|
2022
Q1 | $15.1M | Sell |
341,227
-11,208
| -3% | -$496K | 0.81% | 48 |
|
|
2021
Q4 | $15M | Buy |
352,435
+202
| +0.1% | +$8.58K | 0.7% | 51 |
|
|
2021
Q3 | $15.3M | Buy |
352,233
+807
| +0.2% | +$35K | 0.78% | 53 |
|
|
2021
Q2 | $15M | Sell |
351,426
-21,709
| -6% | -$928K | 0.79% | 49 |
|
|
2021
Q1 | $14.4M | Sell |
373,135
-355
| -0.1% | -$13.7K | 0.84% | 48 |
|
|
2020
Q4 | $13.4M | Buy |
373,490
+8,893
| +2% | +$320K | 0.78% | 51 |
|
|
2020
Q3 | $13.9M | Buy |
364,597
+18,364
| +5% | +$702K | 0.92% | 45 |
|
|
2020
Q2 | $12.2M | Buy |
346,233
+1,142
| +0.3% | +$40.1K | 0.9% | 47 |
|
|
2020
Q1 | $11.3M | Buy |
+345,091
| New | +$11.3M | 1.05% | 39 |
|